Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Calabadions: New Broad-Spectrum Agents to Reverse Neuromuscular Blockade

Buscar en contenido

Contenido:

lunes, 3 de octubre de 2016

qSOFA fails validation

EMCrit
PulmCrit - October 1, 2016 - By Josh Farkas
"Sepsis 3.0 replaced the SIRS criteria with a new risk-stratification tool, qSOFA. qSOFA was initially developed within the Sepsis-3 publication itself. Until now, qSOFA has never been validated. The value of qSOFA vs. SIRS remains controversial...
Summary
  • Churpek et al. 2016 is the first study to attempt validation of qSOFA.
  • qSOFA and SIRS have similar overall performance in predicting the combined outcome of death or ICU transfer. qSOFA has a higher specificity, but this comes as a tradeoff for lower sensitivity.
  • qSOFA is <40% sensitive for detecting a patient who will die or need ICU transfer in 12 hours.
  • qSOFA is consistently out-performed by the NEWS score, a more sophisticated bedside risk-stratification tool (figure below).
  • This study doesn’t support the Sepsis-3 definition. Further evidence is needed before considering the widespread adoption of qSOFA and Sepsis-3. The British approach using the NEWS score appears superior."
simp99